WallStreetZenWallStreetZen

NASDAQ: PMD
Psychemedics Corp Earnings & Revenue

OverviewEarnings
DividendOwnership

PMD past revenue growth

How has PMD's revenue growth performed historically?
Company
-12.45%
Industry
0.12%
Market
17.2%
PMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PMD's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PMD earnings and revenue history

Current Revenue
$22.1M
Current Earnings
-$4.2M
Current Profit Margin
-18.8%

PMD Return on Equity

Current Company
-49.8%
Current Industry
-24%
Current Market
188%
PMD's Return on Equity (-49.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PMD announces earnings.

PMD Return on Assets

Current Company
-27.4%
Current Industry
6.7%
PMD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PMD Return on Capital Employed

Current Company
-45.14%
Current Industry
11.6%
PMD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PMD vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PMD$22.10M-$768.00k-$4.15M-12.33%N/A
TTOO$7.19M-$42.53M-$50.08M-7.29%N/A
TRIB$56.83MN/A-$24.02M-10.15%N/A
STRR$45.79M$26.87M$23.22M-15.16%+34.19%
CHEK$0.00-$19.08M-$17.62MN/AN/A
View Top Diagnostic & Research Stocks

PMD earnings dates

Next earnings date
May 7, 2024

Psychemedics Earnings & Revenue FAQ

What were PMD's earnings last quarter?

On Invalid Date, Psychemedics (NASDAQ: PMD) reported Q4 2023 earnings per share (EPS) of -$0.16, up 33.33% year over year. Total Psychemedics earnings for the quarter were -$945.00 thousand. In the same quarter last year, Psychemedics's earnings per share (EPS) was -$0.12.

If you're new to stock investing, here's how to buy Psychemedics stock.

What was PMD's earnings growth in the past year?

As of Q2 2024, Psychemedics's earnings has grown year over year. Psychemedics's earnings in the past year totalled -$4.15 million.

What is PMD's earnings date?

Psychemedics's earnings date is Invalid Date. Add PMD to your watchlist to be reminded of PMD's next earnings announcement.

What was PMD's revenue last quarter?

On Invalid Date, Psychemedics (NASDAQ: PMD) reported Q4 2023 revenue of $5.00 million up 12.36% year over year. In the same quarter last year, Psychemedics's revenue was $5.70 million.

What was PMD's revenue growth in the past year?

As of Q2 2024, Psychemedics's revenue has grown -12.45% year over year. This is 12.57 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 0.12%. Psychemedics's revenue in the past year totalled $22.10 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.